Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Minerva Medica

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 22193346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum Markers of Hepatocellular Carcinoma

  2010cited by this paper
• Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

  2010cited by this paper
• Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer.

  2010cited by this paper
• Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.

  2009cited by this paper
• Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.

  2009cited by this paper
• Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

  2009cited by this paper
• Monitoring SCCA‐IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis

  2008cited by this paper
• Exon 2 deletion splice variant of γ‐glutamyl carboxylase causes des‐γ‐carboxy prothrombin production in hepatocellular carcinoma cell lines

  2008cited by this paper
• A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.

  2008cited by this paper
• Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.

  2008cited by this paper
• Epidemiology of hepatocellular carcinoma in Japan

  2007cited by this paper
• Squamous cell carcinoma antigen in human liver carcinogenesis

  2007cited by this paper
• New perspectives and strategy research biomarkers for hepatocellular carcinoma

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• A concise review of serum markers for hepatocellular cancer.

  2007cited by this paper
• Structural and functional mapping of alpha-fetoprotein.

  2006cited by this paper
• Progressive increase of SCCA‐IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma

  2006cited by this paper
• Serum markers of hepatocellular carcinoma.

  2006cited by this paper
• Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors

  2005cited by this paper
• Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.

  2005cited by this paper
• Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma

  2005cited by this paper
• Squamous cell carcinoma antigen‐immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma

  2005cited by this paper
• Hepatocellular carcinoma: recent trends in the United States.

  2004cited by this paper
• The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

  2004cited by this paper
• Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

  2004cited by this paper
• Screening for Hepatocellular Carcinoma: Being Old is not All Bad

  2004cited by this paper
• Diagnosis, staging and treatment of hepatocellular carcinoma.

  2004cited by this paper
• Diagnosis and staging of hepatocellular carcinoma.

  2004cited by this paper
• Newer markers for hepatocellular carcinoma.

  2004cited by this paper
• Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

  2004cited by this paper
• Hepatocellular carcinoma: recent trends in Japan.

  2004cited by this paper
• Des‐gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

  2003cited by this paper
• Hepatocellular carcinoma

  2003cited by this paper
• Tumor Markers in Early Diagnosis, Follow-Up and Management of Patients with Hepatocellular Carcinoma

  2002cited by this paper
• Hepatocellular carcinoma: diagnosis and treatment.

  2002cited by this paper
• International trends and patterns of primary liver cancer

  2001cited by this paper
• Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

  2001cited by this paper
• Global cancer statistics in the year 2000.

  2001cited by this paper
• Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1

  2000cited by this paper
• Hepatocellular carcinoma.

  2000cited by this paper
• Rising incidence of hepatocellular carcinoma in the United States.

  1999cited by this paper
• Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C

  1998cited by this paper
• Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel.

  1996cited by this paper
• Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel

  1996cited by this paper
• A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene.

  1995cited by this paper
• Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population

  1995cited by this paper
• Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.

  1993cited by this paper
• Squamous cell carcinoma antigen is a new member of the serine protease inhibitors.

  1991cited by this paper
• Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.

  1987cited by this paper

• Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application

  2024cites this paper
• Construction and validation of a joint diagnosis model based on random forest and artificial intelligence network for hepatitis B-related hepatocellular carcinoma

  2024cites this paper
• Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma

  2023cites this paper
• Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

  2023cites this paper
• Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches

  2023cites this paper
• Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma

  2021cites this paper
• Circulating Biomarkers for Early Diagnosis of Hepatocellular Carcinoma

  2021cites this paper
• Study on The Expression and Correlation of Alpha-Enolase (Eno1) in The Serum of Patients With Hepatocellular Carcinoma

  2021cites this paper
• Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine

  2021cites this paper
• The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia

  2020cites this paper
• Serum Serotonin as a Potential Diagnostic Marker for Hepatocellular Carcinoma

  2019cites this paper
• ASSESSMENT STUDY OF ALPHA-FETOPROTEIN LEVEL AFTER TREATMENT WITH URTICA DIOICA PHENOLIC EXTRACT IN MALE RAT INDUCED BY CARBON TETRA-CHLORIDE

  2018cites this paper
• Exosomal miRNAs in hepatocellular carcinoma development and clinical responses

  2018cites this paper
• A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings

  2018cites this paper
• Bioinformatics analysis of differentially expressed genes in liver cancer for identification of key genes and pathways

  2018cites this paper
• Role of Serum Midkine Level as a Diagnostic Biomarker for Very Early and Early Hepatocellular Carcinoma

  2017cites this paper
• A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China

  2017cites this paper
• Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.

  2017cites this paper
• Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma

  2017cites this paper
• Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of α-fetoprotein, α-fetoprotein-L3, des-γ-carboxy prothrombin, and Golgi protein 73

  2017cites this paper
• Combined use of alcohol in conventional chemical-induced mouse liver cancer model improves the simulation of clinical characteristics of human hepatocellular carcinoma

  2017cites this paper
• Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives

  2016cites this paper
• Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area

  2016cites this paper
• Erratum to: Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma

  2016cites this paper
• Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma

  2016cites this paper
• Chronic hepatitis C: This and the new era of treatment.

  2016cites this paper
• Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study

  2016cites this paper
• Hepatocellular carcinoma and the risk of occupational exposure.

  2016cites this paper
• Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches

  2016cites this paper
• The Clinical Application of Proteomics

  2016cites this paper
• Prognostic Significance of Preoperative Serum Alpha-fetoprotein in Hepatocellular Carcinoma in China

  2015cites this paper
• Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma.

  2015cites this paper
• Biomarkers for the early diagnosis of hepatocellular carcinoma.

  2015cites this paper
• Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics.

  2015cites this paper
• Fine Needle Aspiration Biopsy (FNAB) in the Diagnosis of Hepatocellular Carcinoma: A Review

  2015cites this paper
• Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review

  2015cites this paper
• The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies

  2015cites this paper
• TYPE II MIXED CRYOGLOBULINEMIA IN PATIENTS WITH HEPATITIS C VIRUS: TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN

  2015cites this paper
• Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

  2015cites this paper
• The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma

  2014cites this paper
• Does the preoperative alpha‐fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?

  2014cites this paper
• Hepatocellular carcinoma markers in the omics era: the glycomic analysis.

  2014cites this paper
• Management of Hepatocellular Carcinoma: An Update at the Start of 2014

  2014cites this paper
• Rare Benign Tumors of the Liver: Still Rare?

  2014cites this paper
• The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

  2014cites this paper
• High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential

  2014cites this paper
• Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma

  2014cites this paper
• Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.

  2014cites this paper
• Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies

  2014cites this paper
• Comparison of Long-Term Survival of Patients with Solitary Large Hepatocellular Carcinoma of BCLC Stage A after Liver Resection or Transarterial Chemoembolization: A Propensity Score Analysis

  2014cites this paper
• Elevated Alpha Fetoprotein in Chronic HCV Liver Disease with and without Hepatocellular Carcinoma in Egyptian Patients

  2014cites this paper
• Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients

  2014cites this paper
• Meta-Analysis of the Prognostic and Diagnostic Significance of Serum/Plasma Osteopontin in Hepatocellular Carcinoma

  2014cites this paper
• Biomarkers for virus-induced hepatocellular carcinoma (HCC).

  2014cites this paper
• Development of Biomarkers for Screening Hepatocellular Carcinoma Using Global Data Mining and Multiple Reaction Monitoring

  2013cites this paper
• A Combination of α-Fetoprotein and Des-γ-Carboxy Prothrombin Is Superior in Detection of Hepatocellular Carcinoma

  2013cites this paper
• Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma.

  2013cites this paper
• High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

  2013cites this paper
• Alpha-fetoprotein: a renaissance

  2013cites this paper
• Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis?

  2013cites this paper
• Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization

  2013cites this paper
• Systemic therapies in hepatocellular carcinoma: present and future.

  2013cites this paper
• Impact of PIVKA-II in diagnosis of hepatocellular carcinoma

  2013cites this paper
• Clinical evaluation of single or joint of golgi protein 73 and alpha-fetoprotein in hepatocellular carcinoma diagnosing

  2012cites this paper
• BIOHUMORAL TESTS IN CHRONIC PESTICIDES EXPOSURE

  2012cites this paper
• Elevated serum levels of Chromogranin A in hepatocellular carcinoma

  2012cites this paper
• Hepatocellular carcinoma: present and future.

  2012cites this paper
• An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma

  2012cites this paper
• REGULATION OF HEPATIC GENE EXPRESSION DURING LIVER DEVELOPMENT AND DISEASE

  2012cites this paper
• An overview of biomarkers for the diagnosis of hepatocellular carcinoma.

  2012cites this paper